Occurrence of extended-spectrum beta-lactamases in human and bovine isolates of Escherichia coli from Oyo state, Nigeria

Journal of Infection in Developing Countries

Volumn 8, Issue 6, 2014, Pages 774-779

  Inwezerua, Christiana ^a   Mendonça, Nuno ^b   Calhau, Vera ^b   Domingues, Sara ^b   Adeleke, Olufemi Ezekiel ^a   Da Silva, Gabriela Jorge ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Escherichia coli; Extended spectrum beta lactamases; Genetic mobile elements; Plasmid mediated quinolone resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE CTX M; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; QUINOLONE; TRIMETHOPRIM; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15; BETA-LACTAMASE TEM-1; ESCHERICHIA COLI PROTEIN;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CONJUGATION; BACTERIUM ISOLATION; CATTLE; CONTROLLED STUDY; CULTURE MEDIUM; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENETIC INCOMPATIBILITY; HUMAN; INTEGRON; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; NIGERIA; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; ANIMAL; BOVINE; DEVELOPING COUNTRY; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANIMALS; BETA-LACTAMASES; CATTLE; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENES, BACTERIAL; HUMANS; INTEGRONS; MICROBIAL SENSITIVITY TESTS; NIGERIA; PLASMIDS;

EID: 84902328011     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3430     Document Type: Article

References (20)

1. Pitout JD, Laupland KB (2008) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159-166.
2. Perez F, Endimiani A, Hujer KM, Bonomo RA (2007) The continuing challenge of extended-spectrum β-lactamases. Curr Opin Pharmacol 7: 459-469.
3. Robicsek A, Jacoby GA, Hooper DC (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629-640.
4. Blomberg B, Jureen R, Manji KP (2005) High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended spectrum β-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43: 745-749.
5. Gangoue-Pieboji J, Bedenic B, Koulla-Shiro S (2005) Extended-spectrum β-lactamase producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 43: 3273-3277.
6. Fortini D, Fashae K, Garcia-Fernandez A, Villa L, Carattoli A (2011) Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria. J Antimicrob Chemother 66: 1269-1272.
7. Clinical and Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. M100-S20. CLSI: Wayne, PA.
8. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum-lactamases conferring transferable resistance to newer-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10: 867-878.
9. Mendonça N, Leitão J, Manageiro V, Ferreira E, the Antimicrobial Resistance Surveillance Program in Portugal, Caniça M (2007) Spread of extended-spectrum β-lactamase CTX-M producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51: 1946-1955.
10. Cattoir V, Poirel L, Rotimi V, Claude-James S, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60: 394-397.
11. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC (2006) Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953-3955.
12. Barlow RS, Pemberton JM, Desmarchelier PM, Gobius KS (2004) Isolation and characterization of integron containing bacteria without antibiotic selection. Antimicrob Agents Chemother 48: 838-842.
13. Levesque C, Piche L, Larose C, Roy PH (1995) PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39: 185-191.
14. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: 219-228.
15. Mohapatra BR, Broersma K, Mazumder A (2007) Comparison of five rep-PCR genomic fingerprinting methods for differentiation of fecal Escherichia coli from humans, poultry and wild birds. FEMS Microbiol Lett 277: 98-106.
16. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MCJ, Ochman H, Achtman M (2006) Sex and virulence in Escherichia coli: An evolutionary perspective. Mol Microbiol 60: 1136-1151.
17. Ogbolu DO, Daini OA, Ogunledun A (2011) High Levels of multidrug resistance in clinical isolates of gram-negative pathogens from Nigeria. Int J Antimicrob Agents 37: 62-66.
18. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B (2012) Sequence type ST 131 and ST 10 complex (ST 617) predominant among CTX-M-15 producing Escherichia coli isolates from Nigeria. Clin Microbiol Infect 18: E49-51.
19. Chah KF, Oboegbulem SI (2007) Extended-spectrum β-lactamase production among ampicillin-resistant Escherichia coli strains from chicken in Enugu State, Nigeria. Braz J Microbiol 38: 681-686.
20. Ajayi AO, Oluyege AO, Olowe OA, Famurewa O (2011) Antibiotic resistance among commensal Escherichia coli isolated from faeces of cattle in Ado-Ekiti, Nigeria. J Anim Vet Adv 10: 174-179.